Leptin and Leptin adiponectin ratio may be promising markers for polycystic ovary syndrome and cardiovascular risks

Leptin and LAR in PCOS

Authors

  • Choman Abdullah Mohana COVID-19 unit, Mymenshing Medical College Hospital, Mymenshing, Bangladesh
  • M A Hasanat Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh
  • Emran Ur Rashid Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh
  • Iffat Ara Jahan Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh
  • Md Shahed Morshed Kurmitola General Hospital, Dhaka, Bangladesh
  • Hurjahan Banu Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh
  • Sharmin Jahan COVID-19 unit, Mymenshing Medical College Hospital, Mymenshing, Bangladesh

DOI:

https://doi.org/10.3329/bmrcb.v47i3.59241

Keywords:

Leptin, Adiponectin, Leptin/adiponectin ratio, Polycystic ovary syndrome

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine problem and increasing worldwide. Dysregulated adipocytokine production is thought to be linked with pathogenesis of PCOS.
Objective: The aim of this study was to see the relation of leptin, adiponectin and their ratio with PCOS and its cardiovascular risks.
Methods: This case-control study included 20 PCOS patients diagnosed by revised Rotterdam criteria, 2003 and equal number of age matched control. Relevant clinical information was collected in datasheet. Blood was taken to measure glucose at fasting and after oral glucose tolerance test (OGTT), total testosterone (TT), sex hormone binding globulin (SHBG), luteinizing hormone (LH), follicle stimulating hormone (FSH), insulin, fasting lipid profile, leptin and adiponectin from each participant. Glucose was measured by glucose oxidase, all hormones by chemiluminescent immunoassay, lipids by glycerol phosphate dehydrogenase-peroxidase and leptin as well as adiponectin by enzyme linked immunosorbent assay.
Results: Leptin (ng/ml) [30.0 (24.15, 68.13) vs. 18.80 (9.17, 22.13), p<0.001] and leptin/adiponectin ratio (LAR) [6.0 (4.47, 8.42) vs. 2.14 (1.35, 3.42), p<0.001] were significantly higher in PCOS where as adiponectin (ng/ml) was statistically similar between the groups [6.14 (4.36, 9.66) vs. 6.74 (4.54, 8.62), p=0.820]. PCOS group had significantly higher cardiovascular risks than healthy control when they were categorised according to adiponectin/ leptin ratio (p=0.040). Leptin had significant correlation with waist circumference [r= -0.463, p=0.040], waist/hip ratio (WHR) [r= -0.50, p=0025] and waist/height ratio (WHtR) [r= -0.510, p=0.022] where as LAR with WHR [r= -0.617, p=0.004] and WHtR [r= -0.535, p=0.015]. Leptin [AUC=0.916, p<0.001] and LAR [AUC=0.868, p<0.001] were excellent and fair markers of PCOS respectively.
Conclusion: Leptin and LAR may be promising markers of PCOS and cardiovascular risks.

Bangladesh Med Res Counc Bull 2021; 47(3): 266-272

Downloads

Download data is not yet available.
Abstract
2
PDF
3

Downloads

Published

2022-07-28

How to Cite

Mohana, C. A., Hasanat, M. A., Rashid, E. U., Jahan, I. A., Morshed, M. S., Banu, H., & Jahan, S. (2022). Leptin and Leptin adiponectin ratio may be promising markers for polycystic ovary syndrome and cardiovascular risks: Leptin and LAR in PCOS. Bangladesh Medical Research Council Bulletin, 47(3), 266–272. https://doi.org/10.3329/bmrcb.v47i3.59241

Issue

Vol. 47 No. 3 (2021)

Section

Research Papers

License

Copyright (c) 2022 Choman Abdullah Mohana, M A Hasanat, Emran Ur Rashid, Iffat Ara Jahan, Md Shahed Morshed, Hurjahan Banu, Sharmin Jahan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).